Correlation Between GlaxoSmithKline PLC and Tandem Diabetes
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Tandem Diabetes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Tandem Diabetes into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Tandem Diabetes Care, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Tandem Diabetes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Tandem Diabetes. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Tandem Diabetes.
Diversification Opportunities for GlaxoSmithKline PLC and Tandem Diabetes
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between GlaxoSmithKline and Tandem is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Tandem Diabetes Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tandem Diabetes Care and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Tandem Diabetes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tandem Diabetes Care has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Tandem Diabetes go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Tandem Diabetes
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Tandem Diabetes. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 2.72 times less risky than Tandem Diabetes. The stock trades about -0.3 of its potential returns per unit of risk. The Tandem Diabetes Care is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 3,293 in Tandem Diabetes Care on August 30, 2024 and sell it today you would lose (171.00) from holding Tandem Diabetes Care or give up 5.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Tandem Diabetes Care
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Tandem Diabetes Care |
GlaxoSmithKline PLC and Tandem Diabetes Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Tandem Diabetes
The main advantage of trading using opposite GlaxoSmithKline PLC and Tandem Diabetes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Tandem Diabetes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tandem Diabetes will offset losses from the drop in Tandem Diabetes' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Tandem Diabetes vs. ReShape Lifesciences | Tandem Diabetes vs. Bone Biologics Corp | Tandem Diabetes vs. Tivic Health Systems | Tandem Diabetes vs. Nuwellis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |